Making partnerships work

Article Abstract:

The Universities of Oxford and Cambridge have each formed beneficial ties with the pharmaceutical industry, but each has gone about it in different and original ways. Oxford and the US company Squibb formed a partnership in which the company committed 20 million pounds to fund neuropharmacological research over seven years. Glaxo came to an agreement with Cambridge in which it funds the Glaxo Institute of Applied Pharmacology there with a budget of 16 million pounds over 10 years. The main difference is that company scientists work directly with academics at Cambridge while at Oxford they do not.

Dry, condensed, evaporated products, United Kingdom, Finance, Contracts, University of Oxford, Bristol-Myers Squibb Co., BMY, Glaxo Inc., University of Cambridge, Pharmaceutical research

---

Biotech companies rescue Italian vaccine institute

Article Abstract:

Biocine Co, a joint venture of the biotechnology firms Ciba-Geigy Corp and Chiron Corp, bought the Sclavo Research Institute, Italy's best known center for vaccine development. Biocine paid $62 million for the institute, which is located in Siena and has been renamed the Immunobiological Research Institute Siena (IRIS). Ciba-Geigy and Chiron undertook the purchase to increase their share of the pediatric vaccine market. To help achieve this goal, IRIS will introduce two new vaccines by 1993: one against the Hemophilus influenza B virus and the other against the recombinant pertussis toxin.

Agricultural chemicals, not elsewhere classified, Mergers, acquisitions and divestments, Vaccines industry, Biological products industry, Chiron Corp., CHIR, Biocine Co., Ciba-Geigy Corp.

---

Neglected diseases get vaccine research boost

Article Abstract:

Novartis, the Swiss pharmaceutical company has opened a new Novartis Vaccines Institute for Global Health, which aims at developing new vaccines for several neglected diseases. The institute is a non-profit organization and will mainly focus on the diarrhoeal diseases.

Facilities & equipment, Switzerland, Novartis AG, Buildings and facilities, NVTSY

Similar abstracts:

• Abstracts: Training captive-bred or translocated animals to avoid predators. Learning specificity in acquired predator recognition
• Abstracts: Pushing the frontiers of interdisciplinary research: an idea whose time has come. Laying a firm foundation for interdisciplinary research endeavours
• Abstracts: Human dopamine D1 receptor encoded by an intronless gene on chromosome 5. Direct protein-protein coupling enables cross-talk between dopamine D5 and gamma-aminobutryric acid A receptors
• Abstracts: Evaluation of alternative techniques to determine pork carcass value. Genotype and treatment biases in estimation of carcass lean of swine
• Abstracts: Science panel's report could end whaling ban. Japan wants global guidelines for joint research projects. Computing in the real world

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.